AACR 2026: A deep learning pathomics platform may help predict response to immunotherapy in lung cancer patients
A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response…
Browsing: AACR
AACR 2026: Exposure to wildfire smoke may be linked to increased risk of developing several cancers
Exposure to wildfire smoke was associated with a significantly increased risk of lung, colorectal, breast,…
AACR 2026: Novel approach prevents cancer progression, spares surgery for majority of patients with precancerous oral lesions
Direct injection of a low dose of the immune checkpoint inhibitor nivolumab into precancerous oral…
AACR 2026: CAR T therapy delivers deep responses in high-risk smouldering myeloma
A phase 2 trial, CAR-PRISM, suggests that early use of CAR T cell therapy may…
S3E6 The Oncology Journal Club
Welcome to Part 2 of the 2025 ASCO ASM Special of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson to unpack practice changing presentations from Chicago.
AACR 2025: A topical BRAF-inhibiting gel may mitigate acneiform rash in patients receiving EGFR-targeted therapy for colorectal cancer
Patients with colorectal cancer who had acneiform rash and applied LUT014 gel, an investigational topical BRAF inhibitor,…
AACR 2025: Single-cell RNA sequencing provides comprehensive map of acute myeloid leukemia cell states
A new gene expression atlas developed using single-cell RNA sequencing data shows how normal hematopoietic…
TAR-200 monotherapy demonstrates highest complete response rate reported to date with sustained clinical benefits in patients with certain types of bladder cancer
New data from Cohort 2 of the Phase 2b SunRISe-1 study evaluating TAR-200—an intravesical gemcitabine…
AACR 2025: Pretrained machine learning models may help accurately diagnose non-melanoma skin cancer in resource-limited settings
Artificial intelligence models, pretrained on vast datasets, significantly outperformed a standard baseline model in identifying…
AACR 2025: AI-driven biomarker model may improve detection of cancer cachexia
A multimodal, artificial intelligence (AI)-driven model that analyses routinely collected imaging and clinical information led…